COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP

Alessandro Busca; Jon Salmanton-García; Paolo Corradini; Francesco Marchesi; Alba Cabirta; Roberta Di Blasi; Remy Dulery; Sylvain Lamure; Francesca Farina; Barbora Weinbergerová; Josip Batinić; Anna Nordlander; Alberto López-García; Ľuboš Drgoňa; Ildefonso Espigado-Tocino; Iker Falces-Romero; Ramón García-Sanz; Carolina García-Vidal; Anna Guidetti; Nina Khanna; Austin Kulasekararaj; Johan Maertens; Martin Hoenigl; Nikolai Klimko; Philipp Koehler; Antonio Pagliuca; Francesco Passamonti; Oliver Cornely; Livio Pagano

doi:10.1182/bloodadvances.2021005616

Back

COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP

Journal article

Open access

Peer reviewed

COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP

Alessandro Busca, Jon Salmanton-García, Paolo Corradini, Francesco Marchesi, Alba Cabirta, Roberta Di Blasi, Remy Dulery, Sylvain Lamure, Francesca Farina, Barbora Weinbergerová, …

Blood Advances, Vol.6(7), pp.2427-2433

12/04/2022

DOI: https://doi.org/10.1182/bloodadvances.2021005616

PMCID: PMC8575532

PMID: 34749396

Abstract

COVID-19

Humans

Immunotherapy, Adoptive

Receptors, Chimeric Antigen

T-Lymphocytes

Key Points The EHA-IDWP developed an observational registry collecting data on COVID-19 infection in patients who received CAR T-cell therapy. Prevalence of COVID-19 was 4.8%, and overall mortality was 50%, highlighting the need for prevention of infection in these patients.

Files and links (1)

url

Find in HALView

Metrics

1 Record Views

Details

Title: COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP
Creators - without role: Alessandro Busca - Azienda Ospedaliera Citta' della Salute e della Scienza di Torino
Jon Salmanton-García - University Hospital Cologne
Paolo Corradini - Tumori Foundation
Francesco Marchesi - IFO - Istituto Nazionale Tumori Regina Elena [Roma]
Alba Cabirta - Vall d'Hebron Hospital Universitari
Roberta Di Blasi - Hôpital Saint-Louis
Remy Dulery - Hôpital Saint-Antoine
Sylvain Lamure - Université de Montpellier, Institut de Génétique Moléculaire de Montpellier - IGMM
Francesca Farina - IRCCS Ospedale San Raffaele
Barbora Weinbergerová - University Hospital Brno
Josip Batinić - Croatian Chamber of Economy
Anna Nordlander - Karolinska University Hospital
Alberto López-García - Hospital Universitario Fundación Jiménez Díaz
Ľuboš Drgoňa - Comenius University Bratislava
Ildefonso Espigado-Tocino - Hospital Universitario Virgen del Rocío
Iker Falces-Romero - Hospital Universitario La Paz
Ramón García-Sanz - Complejo Hospitalario de Salamanca
Carolina García-Vidal - Hospital Universitari de Vic
Anna Guidetti - Fondazione IRCCS Istituto Nazionale dei Tumori
Nina Khanna - University Hospital of Basel
Austin Kulasekararaj - King's College Hospital
Johan Maertens - KU Leuven
Martin Hoenigl - University of California, San Diego
Nikolai Klimko - North-Western State Medical University [St Petersburg, Russia]
Philipp Koehler - University Hospital Cologne
Antonio Pagliuca - King's College Hospital
Francesco Passamonti - Azienda Socio Sanitaria Territoriale Lariana
Oliver Cornely - Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases
Livio Pagano - Agostino Gemelli University Polyclinic
Publication Details: Blood Advances, Vol.6(7), pp.2427-2433
Identifiers: 9937490109311
Academic Unit: Institut de Génétique Moléculaire de Montpellier - IGMM
Language: English
Resource Type: Journal article
Local Fields: hal-03645421